Lantern Pharma LTRN
NASDAQ LTRN
$0.64 -0.03 (-4.05%)
At close: Oct 19, 2026 · 4:00 PM EDT

Lantern Pharma (LTRN) Selling, General & Administrative (2019 - 2026)

Updated

Lantern Pharma's Selling, General & Administrative came in at $1.72 million for Q2 2026, up 8.4% from $1.58 million a year earlier and up 2.2% from the prior quarter.

Analysis

Lantern Pharma (LTRN) Selling, General & Administrative (2019 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Lantern Pharma reported Selling, General & Administrative of $6.77 million, up 9.5% year-over-year; for FY2025, it came in at $6.46 million, up 6.1% from FY2024.

  • Selling, General & Administrative has increased in each of the last six years, with a five-year compound annual growth rate of 12.0% (FY2020 to FY2025).
  • Going back by year, Selling, General & Administrative was $6.09 million in FY2024 (+1.8%), $5.98 million in FY2023 (+2.6%), $5.83 million in FY2022 (+16.1%) and $5.02 million in FY2021 (+37.0%).
  • The five-year range for quarterly Selling, General & Administrative is $1.18 million (Q3 2021) to $1.91 million (Q3 2025).
  • Year-over-year, Selling, General & Administrative increased in seven of the last eight quarters, with growth averaging 10.3%.
  • The fastest year-over-year change in Selling, General & Administrative over five years came in Q3 2025 (growth of 30.8%), and the weakest in Q4 2023 (a decline of 17.2%).
  • Business Quant data shows LTRN's Selling, General & Administrative at $1.68 million (Q1 2026), $1.46 million (Q4 2025) and $1.91 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,109.83 Bn 1,078.42 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 610.61 Bn 529.14 Bn 17.26 Bn 6.43 Bn
3 AbbVie 500.66 Bn 473.77 Bn 12.70 Bn 3.63 Bn
4 Merck 354.64 Bn 309.02 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 291.14 Bn 255.13 Bn 11.24 Bn 3.24 Bn
6 Astrazeneca 254.18 Bn 227.87 Bn 12.86 Bn 5.65 Bn
7 Amgen 229.46 Bn 184.86 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 190.33 Bn 164.53 Bn 6.22 Bn 1.92 Bn
9 Pfizer 167.92 Bn 114.57 Bn 10.94 Bn 3.41 Bn
10 Lantern Pharma 7.95 Mn -28.21 Mn - 1.72 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 1.72 Mn
Mar 31, 2026 1.68 Mn
Dec 31, 2025 1.46 Mn
Sep 30, 2025 1.91 Mn
Jun 30, 2025 1.58 Mn
Mar 31, 2025 1.51 Mn
Dec 31, 2024 1.63 Mn
Sep 30, 2024 1.46 Mn
Jun 30, 2024 1.52 Mn
Mar 31, 2024 1.48 Mn
Dec 31, 2023 1.30 Mn
Sep 30, 2023 1.31 Mn
Jun 30, 2023 1.63 Mn
Mar 31, 2023 1.73 Mn
Dec 31, 2022 1.57 Mn
Sep 30, 2022 1.44 Mn
Jun 30, 2022 1.41 Mn
Mar 31, 2022 1.41 Mn
Dec 31, 2021 1.35 Mn
Sep 30, 2021 1.18 Mn
API Access

Lantern Pharma Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=LTRN&period=max&api_key=YOUR_API_KEY